Clinical Trial Update: PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism [NA]

View source ↗

Summary

Clinical trial update for the PETAL study evaluating whether Gallium-68 Pentixafor PET-CT improves surgical outcomes in primary aldosteronism; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosterone-producing Adenoma
• Aldosteronism
• Hypertension
• Idiopathic Hyperaldosteronism

Drugs mentioned

• 68Ga-Pentixafor PET tracer (pentixafor)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Primary Aldosteronism, Secondary Hypertension | NA | Status: RECRUITING